Works matching IS 00302414 AND DT 2020 AND VI 98 AND IP 3
Results: 10
Expression of c-Met in Primary and Recurrent Hepatocellular Carcinoma.
- Published in:
- Oncology, 2020, v. 98, n. 3, p. 186, doi. 10.1159/000504806
- By:
- Publication type:
- Article
Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer.
- Published in:
- Oncology, 2020, v. 98, n. 3, p. 179, doi. 10.1159/000504651
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Oncology, 2020, v. 98, n. 3, p. 1, doi. 10.1159/000506784
- Publication type:
- Article
Interleukin-6: A Masterplayer in the Cytokine Network.
- Published in:
- Oncology, 2020, v. 98, n. 3, p. 131, doi. 10.1159/000505099
- By:
- Publication type:
- Article
Does the Timing of Surgery after Neoadjuvant Therapy in Breast Cancer Patients Affect the Outcome?
- Published in:
- Oncology, 2020, v. 98, n. 3, p. 168, doi. 10.1159/000504964
- By:
- Publication type:
- Article
Anesthesia in Combination with Propofol Increases Disease-Free Survival in Bladder Cancer Patients Who Undergo Radical Tumor Cystectomy as Compared to Inhalational Anesthetics and Opiate-Based Analgesia.
- Published in:
- Oncology, 2020, v. 98, n. 3, p. 161, doi. 10.1159/000504807
- By:
- Publication type:
- Article
The Five-Year Survival Rate of Patients with Nasopharyngeal Carcinoma Based on Tumor Response after Receiving Neoadjuvant Chemotherapy, Followed by Chemoradiation, in Indonesia: A Retrospective Study.
- Published in:
- Oncology, 2020, v. 98, n. 3, p. 154, doi. 10.1159/000504449
- By:
- Publication type:
- Article
Comparative Study of the Safety and Efficacy of First-Line Cisplatin and Carboplatin Chemotherapy in Elderly Patients with Metastatic Urothelial Carcinoma.
- Published in:
- Oncology, 2020, v. 98, n. 3, p. 146, doi. 10.1159/000504393
- By:
- Publication type:
- Article
Expression and Clinical Significance of POLR1D in Colorectal Cancer.
- Published in:
- Oncology, 2020, v. 98, n. 3, p. 138, doi. 10.1159/000504174
- By:
- Publication type:
- Article
Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience.
- Published in:
- Oncology, 2020, v. 98, n. 3, p. 174, doi. 10.1159/000504578
- By:
- Publication type:
- Article